Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 01)
Gabapentin Tablet
Product Images NDC 71335-3060
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-3060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 02)
This text provides information about a study design involving two different treatment periods: a 4-week fixed dose period and a placebo period. The treatments evaluated in the study include Gabapentin at a dose of 3600 mg/day and a placebo. The study lasts for multiple weeks, although the exact number is not provided in the text.*
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 03)
This text provides information on a study involving the evaluation of pain scores over different doses of Gabapentin and placebo. The study includes a baseline measurement and depicts the mean pain scores at 3 weeks with a titration period and at 4 weeks with a fixed dose period for each treatment group.*
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 04)
This text likely describes a study on Responders (patients with 50% reduction in pain score) in Controlled PHN Studies comparing different treatments such as PBO, GBP 3600, GBP 800, and GBP 2400. The data suggests that Study 2 had a higher proportion of responders compared to Study 1. The statistical significance is indicated by the p-values provided.*
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 05)
This data appears to show the percentage difference in daily dose (in milligrams) between three different studies. The values in the table represent the percentage differences at different doses of the medication being studied. It seems that the studies labeled "Study a", "Study b", and "Study c" are comparing dosages at 600 mg, 900 mg, 1200 mg, and 1800 mg. The table provides insights into the variations in dosage amounts among the studies.*
Label (Lbl713353060)
This is a description for Gabapentin 600 mg film-coated tablets. It provides information on the dosage, storage conditions, and precautions to keep the medication out of reach of children. The tablets should be stored at a temperature range of 20°C to 25°C. Additionally, there is a reminder for pharmacists to dispense a medication guide to each patient. The text also includes details on the manufacturer and repackager of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
